FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
Europe’s healthcare – A right or a business model? MEPs face off in The Ring
Published on 18/03/2026 – 21:30 GMT+1 Did you know that the price of a pill and the waiting…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
Scientists turn plastic waste into Parkinson’s drug levodopa using engineered bacteria
A novel engineered microbial system transforms discarded plastic into a frontline Parkinson’s treatment, offering a glimpse into a…
Ozempic Maker Sued After Woman Died From Stomach Paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after…
FDA telehealth crackdown highlights role of national doctor networks
The Food and Drug Administration is cracking down on telehealth companies’ marketing of compounded versions of weight loss…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
Zealand stock plummets after trial setback, CEO remains optimistic
Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management…
Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink…
TrumpRx: High expectations, but limited impact a month after launch
WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Gene-modified pancreas cells offer hope for people with type 1 diabetes
Key Insights A proof-of-concept trial in a single patient has shown that genetically engineered pancreas cells can…